Intraocular Pressure

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

An innovative technique combining goniosynechialysis and goniotomy achieved clinically meaningful IOP-lowering effects in patients with angle-closure glaucoma, according to a study.

Patients with primary open-angle glaucoma implanted with two iStents experienced a similar IOP reduction and required fewer add-on medications compared with patients treated with a once-a-day travoprost.

Earlier this year, The Lancet published the results of the LiGHT trial, comparing selective laser trabeculoplasty and eye drops to treat patients with open-angle glaucoma, which found SLT provided more robust IOP lowering while being a more cost-efficient first-line treatment.

PARIS — In patients with uncontrolled open-angle glaucoma, better reduction of IOP was achieved when ab interno trabeculotomy was added to the combined treatment of phacoemulsification plus endocyclophotocoagulation than when it was not added, according to a study.

PARIS — The HORIZON trial at 3 years demonstrated that the Hydrus Schlemm’s canal stent added sustained IOP lowering to that achieved by cataract surgery alone, Gus Gazzard, MD, MBBChir, FRCOphth, said at the European Society of Cataract and Refractive Surgeons meeting.

The Iluvien implant has received regulatory approval from the Australian Therapeutic Goods Administration for the treatment of diabetic macular edema, Alimera Sciences announced.